؉ channel subunits may form homomeric or heteromeric channels with distinct functional properties. Hyperpolarizing commands delivered to Xenopus oocytes expressing homomeric K ir 4.1 channels evoke inwardly rectifying K ؉ currents which activate rapidly and undergo a pronounced decay at more hyperpolarized potentials. In addition, K ir 4.1 subunits form heteromeric channels when coexpressed with several other inward rectifier subunits. However, coexpression of K ir 4.1 with K ir 3.4 causes an inhibition of the K ir 4.1 current. We have investigated this inhibitory effect and show that it is mediated by interactions between the predicted transmembrane domains of the two subunit classes. Other subunits within the K ir 3.0 family also exhibit this inhibitory effect which can be used to define subgroups of the inward rectifier family. Further, the mechanism of inhibition is likely due to the formation of an "inviable complex" which becomes degraded, rather than by formation of stable nonconductive heteromeric channels. These results provide insight into the assembly and regulation of inwardly rectifying K ؉ channels and the domains which define their interactions.
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Inwardly rectifying potassium channels (K ir ) 1 are found in a wide variety of tissues and cell types where they are involved in the maintenance of the resting membrane potential and control of excitability (1) (2) (3) (4) (5) (6) . The diversity of these channels can at least in part be explained by the growing number of cloned inward rectifier subunits (7) (8) (9) (10) (11) (12) (13) (14) . In addition, as with voltagedependent potassium channels (K v ), diversity is enhanced by the ability of inward rectifier subunits to form homomeric or heteromeric channels. For example, coexpression of K ir 4 (16, 18, 19) . Also, an inhibitory effect of K ir 3.3 upon K ir 3.2 channel activity has been reported although the mechanism has not been determined (19) .
In this study, we have investigated the effects of coexpression of K ir 3.4 with K ir 4.1. In this case, the effect is neither a potentiation nor a modification of channel activity, rather an inhibitory "dominant-negative" effect upon K ir 4.1 currents. We show that this effect on K ir 4.1 is also endowed by other members of the K ir 3.0 family, and that the TMs are the structural elements which mediate the inhibitory interactions. Further analysis suggests that the inhibitory interactions occur shortly after translation and that the resulting complexes are degraded rather than processed as nonconducting complexes to the plasma membrane.
EXPERIMENTAL PROCEDURES
Electrophysiology-Xenopus laevis care and handling were in accordance with the highest standards of institutional guidelines. Frogs underwent no more than two surgeries, separated by at least 3 weeks. Frogs were anesthetized with an aerated solution of 3-aminobenzoic acid ethyl ester. Standard recording solution contained 90 mM KCl, 3 mM MgCl 2 , 10 mM HEPES (pH 7.4) unless otherwise stated. Microelectrodes were filled with 3 M KCl and had resistances of 0.1-0.5 M⍀. Recordings were performed at 22°C, 24 -36 h after injection using a Geneclamp 500 amplifier (Axon Instruments) interfaced to a Macintosh Quadra 800 computer. Currents were evoked by voltage commands from a holding potential of Ϫ5 mV, delivered in Ϫ10-mV increments from 40 mV to Ϫ100 mV, unless otherwise stated. Data collection and analyses were performed using Pulse, PulseFit (Heka), and IGOR (Wavemetrics) software. Values for the average whole cell current were obtained by measuring the steady state current at Ϫ100 mV. All data are presented as the mean Ϯ S.E. for groups of at least six oocytes (actual numbers used in each group are indicated above the bars) and are expressed as the percentage of control current observed for an identical group of oocytes injected with an equivalent amount of K ir 4.1 mRNA. In all cases, the amount of K ir 4.1 mRNA and the volume injected per oocyte were held constant at approximately 0.1 ng in 50 nl, which would typically result in the 10 -15 A of current 24 -36 h after injection. All coinjected mRNAs were varied according to the ratios described in the text, e.g. a 10-fold excess of K ir 3.4 (10:1 ratio) was obtained by coinjecting 1 ng of K ir 3.4 ϩ 0.1 ng of K ir 4.1 mRNA per oocyte.
Molecular Biology-All channel subunits were subcloned into the oocyte expression vector pBF (graciously provided by Dr. B. Fakler) 3 which provides 5Ј-and 3Ј-untranslated regions from the Xenopus ␤-globin gene flanking a polylinker containing multiple restriction sites. In vitro mRNAs were generated using SP6 polymerase (Life Technologies, Inc.); following synthesis, mRNAs were evaluated spectrophotometrically and by ethidium bromide staining after agarose gel electrophoresis. Chimeras were generated by a method described by Horton et al.(20) in which the chimeric junctions were generated by overlap extension of PCR primers which encoded the desired sequence. The subunit domains are defined by the following amino acids: K ir 3.4, N terminus, amino acids 1-82; TM1, amino acids 83-116; pore, amino acids 117-164; TM2, amino acids 165-192; C terminus, amino acids 192-419; K ir 4.1, N terminus, amino acids 1-60; TM1, amino acids 61-93; pore, amino acids 94 -143; TM2, amino acids 144 -170; C terminus, amino acids 171-379. To engineer the FLAG epitope onto the C terminus of K ir 4.1, an oligonucleotide which deleted the K ir 4.1 stop codon and added 24 nucleotides encoding the 8-amino acid epitope and a translational stop codon was employed in the polymerase chain reaction. All polymerase chain reactions were performed using VENT polymerase (New England Biolabs) according to the manufacturer's instructions. The nucleotide sequences of all chimeric junctions and polymerase chain reaction products were verified before use. Oligonucleotides were synthesized on an Applied Biosystems 391 DNA synthesizer.
Membrane Preparation and Western Blot Analysis-Total oocyte membranes were prepared using a method modified from Geering et al. (21) . 25 oocytes were suspended in 1 ml of phosphate-buffered saline (50 mM phosphate, 150 mM NaCl, pH 8.0) containing 0.1 mM phenylmethylsulfonyl fluoride and 5 g/ml each of leupeptin, aprotinin, and pepstatin A and homogenized, first by 5 passages through an 18-gauge needle and then one passage through a 27-gauge needle. The homogenates were centrifuged repeatedly at 1,000 ϫ g for 10 min at 4°C until all yolk granules and melanosomes were pelleted, typically 3-4 times. The final supernatant was pelleted at 165,000 ϫ g for 30 min to generate a total membrane fraction devoid of yolk granules. This membrane pellet was resuspended in 25 l of phosphate-buffered saline, and samples were subjected to SDS-polyacrylamide gel electrophoresis using a 10% resolving gel and 3% stacking gel in a Bio-Rad Miniprotean II apparatus. 20% of each sample, representing 4 oocytes, was loaded in each lane. Proteins were transferred to nitrocellulose filters, and Western blot analysis was performed using the m2-FLAG monoclonal antibody (IBI, Eastman Kodak Co.). Antibodies were detected using the Amersham ECL-detection system according to the manufacturer's instructions. 3 .0 Family-Injection of mRNA encoding K ir 4.1 into Xenopus oocytes results in hyperpolarization-activated, inward potassium currents which have a time-dependent decay at more negative potentials ( Fig. 1a ; Refs. 10 and 22). In contrast, hyperpolarizing commands delivered to oocytes injected with K ir 3.4 mRNA do not evoke macroscopic channel activity different from control oocytes ( Fig. 1b; Ref. 16 ). However, coexpression of K ir 3.4 with K ir 4.1 results in a reduction of K ir 4.1 whole cell currents that is proportional to the ratio of K ir 3.4 to K ir 4.1 mRNA injected (Fig. 1, c and e) . Indeed, when K ir 3.4 mRNA is coinjected in a 10-fold excess to K ir 4.1, all current is abolished (Fig. 1, d and e) . Inhibition of the K ir 4.1 current is not due to effects of excess mRNA on translation because coinjection of K ir 4.1 with an equivalent excess of mRNA for another membrane protein, the dopamine D2 receptor, does not affect K ir 4.1 current amplitudes ( Fig. 1e; Ref. 23 ).
RESULTS

Inhibition of K ir 4.1 by K ir 3.4 and Other Members of the K ir
The reduced K ir 4.1 currents evoked from coinjected oocytes were not different from K ir 4.1 currents recorded from oocytes injected only with K ir 4.1 mRNA. Fitting the time-dependent component of the whole cell current trace recorded at Ϫ100 mV with a double exponential yielded time constants of f ϭ 57.7 Ϯ 2.5 ms and s ϭ 366.0 Ϯ 11.0 ms (A f ϭ 76.6%, n ϭ 6) for oocytes injected only with K ir 4.1, and of f ϭ 50.0 Ϯ 1.2 ms and s ϭ 277.2 Ϯ 9.9 ms (A f ϭ 85.1%, n ϭ 6) for oocytes injected with a 1:1 ratio of K ir 4.1 and K ir 3.4 mRNAs. These results suggest a specific inhibitory effect of K ir 3.4 upon K ir 4.1.
To determine if other members of the K ir 3.0 subfamily had a similar effect on K ir 4.1, K ir 3.1 (8, 24) , and K ir 3.2 (14, 12) were coexpressed with K ir 4.1. As shown in Fig. 2 , both of these K ir 3.0 subfamily members had similar inhibitory effects upon K ir 4.1 current amplitudes. To test whether K ir 3.4 inhibits other inward rectifier subunits, K ir 1.1 (9), a subunit closely related to K ir 4.1, was coexpressed with K ir 3.4. Currents evoked following coexpression of K ir 1.1 and K ir 3.4 were reduced compared to oocytes expressing only K ir 1.1, similar to the effects on K ir 4.1 (currents reduced to Ͻ5% of controls; not shown).
Inhibition Is Mediated by the Transmembrane Domains-To localize structural elements responsible for the inhibitory interactions between members of these two inward rectifier subfamilies, a panel of chimeras between K ir 3.4 and K ir 4.1 was constructed ( Fig. 3 ; see "Experimental Procedures"). When expressed alone, chimeras 1413, 1414, and 1415, all containing the TM/pore region of K ir 3.4, did not produce currents different from control oocytes. In contrast, chimeras 1407, 1408, and 1409 which share a common structural domain, the TM/pore region of K ir 4.1, did yield significant channel activity resembling K ir 4.1 currents (Fig. 3) .
To determine which domains mediate the inhibitory effect of K ir 3.4 upon K ir 4.1, chimeras 1413, 1414, and 1415 were coexpressed in a 10-fold excess to K ir 4.1 and chimeras 1407, 1408, and 1409 with a 10-fold excess of K ir 3.4 mRNA. The table in Fig. 3 shows that those chimeras with the TM/pore domains of K ir 3.4 (1413, 1414, and 1415) had an inhibitory effect on K ir 4.1, while chimeras 1407, 1408, and 1409, which contain the TM/pore region of K ir 4.1, were inhibited by coexpression with K ir 3.4. Therefore, the structural elements which mediate inhibition reside within the TM/pore domain.
To further localize the structural elements responsible for the inhibitory interactions, three more chimeras were constructed in which K ir 4.1 contained either the first, second, or both transmembrane domains of K ir 3.4 (Fig. 4a) . None of these three chimeras was functional when expressed alone, and coexpression of K ir 4.1 and 1417 or 1418, the chimeras containing either one or the other of the K ir 3.4 TMs, had no significant effect upon K ir 4.1 currents. In contrast, coexpression of K ir 4.1 and 1419, the chimera with both K ir 3.4 TM domains, inhibited K ir 4.1 currents, similar to the inhibition by wild type K ir 3.4 (Fig. 4b ). These results demonstrate that both TMs are necessary and sufficient for inhibition of K ir 4.1 channel activity.
Inhibition Results in Subunit Degradation-To investigate the mechanism of inhibition, the 8-amino acid FLAG epitope tag was engineered onto the C terminus of the K ir 4.1 subunit (K ir 4.1-F), permitting immunological detection with a monoclonal antibody (m2-FLAG ab). Currents recorded from oocytes injected with K ir 4.1-F mRNA were indistinguishable from those recorded from oocytes injected with wild type K ir 4.1 mRNA and, when coinjected with K ir 3.0 mRNA, currents were reduced similar to coexpression with unmodified K ir 4.1 (not shown).
Total membranes were prepared from oocytes injected with either K ir 4.1-F mRNA alone or from oocytes coinjected with K ir 4.1-F mRNA plus a 10-fold excess of test mRNAs. The membrane fractions were prepared as a Western blot and probed with the m2-FLAG antibody (Fig. 5) . The K ir 4.1-F protein was detected by the m2-FLAG antibody as a protein of approximately 40 kDa, in close accord with its predicted molecular mass (41.1 kDa); the fainter bands of higher molecular weight likely represent aggregates of the K ir 4.1-F protein. These bands were not detected from mock injected oocytes (not shown) or oocytes coinjected with an excess of K ir 3.4, 1419, K ir 3.1, or K ir 3.2 mRNAs, in which K ir 4.1-F currents were completely inhibited (Ͻ6% of the control current). However, the K ir 4.1-F protein was detected in oocytes coinjected with mRNAs encoding K ir 4.1-F and the D2 receptor, K ir 1.1, or the two transmembrane chimeras which do not inhibit K ir 4.1 (1417 and 1418); currents from these oocytes were not reduced compared to control oocytes expressing K ir 4.1-F (Fig. 5) .
When injected at a 10-fold excess, all members of the K ir 3.0 family tested, as well as chimera 1419, abolish the K ir 4.1 current and result in undetectable levels of the K ir 4.1-F protein, suggesting that they act through a common mechanism. Because the membrane preparations contained intracellular as well as plasma membrane compartments, it is likely that co- expression of K ir 4.1 and K ir 3.4 results in degradation of heteromeric complexes. If this is the case, then temporally separating the expression of K ir 4.1 and K ir 3.4 might separate coassembly of these subunits and allow K ir 4.1 channels to reach the plasma membrane. To test this hypothesis, oocytes were injected with a 10-fold excess of K ir 3.4 mRNA either 12 h before or 12 h after injection of a constant amount of K ir 4.1 mRNA. Fig. 6 shows that if the expression of either subunit is delayed by 12 h then approximately 50% of the control K ir 4.1 current is observed. However, if the two are simultaneously coinjected, then K ir 4.1 currents are abolished. These results suggest that coassembly of K ir 4.1 and K ir 3.4 subunits occurs shortly after translation, and temporally separating translation of the two classes of mRNAs reduces the likelihood of heteromer formation.
DISCUSSION
Coexpression of members of the K ir 3.0 family with K ir 4.1 inhibits K ir 4.1 currents, an effect which is likely due to cotranslational subunit assembly and subsequent degradation of the heteromeric complexes. The structural motifs which mediate the inhibitory interactions of K ir 3.4 with K ir 4.1 reside within the putative TMs, and, while these are the only necessary structural motifs, both are required for inhibition.
The inhibition of K ir 4.1 currents by K ir 3.4 is not due to nonspecific effects on translation, because coexpression of K ir 4.1 with an equivalent amount of additional mRNA encoding another membrane protein, such as the dopamine D2 receptor, is without effect. Further, K ir 3.4 has a similar inhibitory effect upon K ir 1.1 (9), another inward rectifier which is closely related to K ir 4.1. The inhibition of K ir 4.1 and related subunits by members of the K ir 3.0 family thus provides an additional criterion for inward rectifier subunit classification (25) .
The observation that both TMs are required for the inhibitory interaction suggests that when a single TM is swapped for that of another family, the subunits cannot be coassembled. Chimera 1419 which has both K ir 3.4 TMs is capable of interacting with K ir 4.1 subunits and inhibiting the current similar to K ir 3.4. Although the structural domains which mediate inhibitory interactions between members of the K ir 3.4 subfamily and K ir 4.1 are different from the domains which mediate coassembly of distinct K v subunits, both K ir and K v subunit coassembly may occur cotranslationally (26) .
The mechanism of inhibition appears to act through sequestration of heteromeric complexes into a degradative pathway soon after translation and before insertion in the plasma membrane. If heteromeric channels are processed to the plasma membrane as inactive complexes or if subunit coassembly occurs by association within the plasma membrane, then the K ir 4.1-F subunit should be detected in oocytes coinjected with K ir 4.1-F and K ir 3.4 mRNAs. However, K ir 4.1-F subunits were not detected by Western blot, even though the preparations did not separate intracellular and plasma membrane compartments. In addition, the inhibitory interactions were uncoupled by temporally separating expression of the two different subunit types. Thus, when K ir 4.1 subunits are allowed to assemble together before interference from K ir 3.4 subunits, they are processed to the plasma membrane as functional channels, and, conversely, when K ir 3.4 subunits have already assembled together, subsequent inhibition of K ir 4.1 is reduced. However, when they are simultaneously expressed, as shown above, K ir 4.1 currents are abolished. The fact that other members of the K ir 3.0 family also had the same effect implies that the mechanism of inhibition by members of this family is the same.
There are several tissues, including the heart and brain, where members of the K ir 3.0 family and the subunits they inhibit are coexpressed. In atrial myocytes for example, K ir 3.4 and K ir 3.1 coassemble to form the channel underlying I KAch (16) , but K ir 4.1 is also expressed in this tissue (10) . It is possible that the inhibitory interaction described here between the K ir 3.4 and K ir 4.1 provides a way for the cell to prevent either inactive or possibly disruptive heteromeric complexes from reaching the plasma membrane, reflecting an additional physiological mechanism which regulates the array of distinct inward rectifier subtypes. 
